Heidelberg Pharma AG (ETR:HPHA)

BRIEF

published on 09/04/2025 at 09:51, 3 months ago

Heidelberg Pharma to Present New HDP-101 Data at IMS Annual Meeting

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS Annual Meeting
BRIEF

published on 09/04/2025 at 09:51, 3 months ago

Heidelberg Pharma présentera de nouvelles données sur le HDP-101 lors de la réunion annuelle de l'IMS

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Réunion Annuelle De L'IMS
PRESS RELEASE

published on 09/04/2025 at 09:46, 3 months ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
Heidelberg Pharma announces new clinical data for lead ATAC candidate HDP-101 to be presented at the International Myeloma Society Annual Meeting 2025

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate International Myeloma Society
BRIEF

published on 08/28/2025 at 03:55, 3 months 8 days ago

La FDA demande des données supplémentaires à Telix Pharmaceuticals, retardant ainsi le paiement à Heidelberg Pharma

Heidelberg Pharma Mise À Jour Réglementaire TLX250-CDx Conséquences Financières Demande De La FDA
BRIEF

published on 08/28/2025 at 03:55, 3 months 8 days ago

FDA Requests Additional Data from Telix Pharmaceuticals, Delaying Payment to Heidelberg Pharma

Heidelberg Pharma Regulatory Update TLX250-CDx FDA Request Financial Implications
PRESS RELEASE

published on 08/28/2025 at 03:50, 3 months 8 days ago

EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026

FDA Approval Heidelberg Pharma HealthCare Royalty Telix Pharmaceuticals TLX250-CDx
BRIEF

published on 07/10/2025 at 07:08, 4 months 26 days ago

Heidelberg Pharma's Promising Mid-Year 2025 Developments

Leadership Changes Royalty Agreement Financial Developments HDP-101 Trials HDP-102 Introduction
BRIEF

published on 07/10/2025 at 07:08, 4 months 26 days ago

Développements prometteurs de Heidelberg Pharma pour la mi-année 2025

Changements De Direction Évolution Financière Accord De Redevances Essais HDP-101 Présentation Du HDP-102
PRESS RELEASE

published on 07/10/2025 at 07:03, 4 months 26 days ago

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning

Financial Report Clinical Trials HDP-101 Heidelberg Pharma AG ATAC Candidates
BRIEF

published on 05/27/2025 at 08:12, 6 months 9 days ago

Heidelberg Pharma Begins Phase I Study for HDP-102 in Non-Hodgkin Lymphoma

Heidelberg Pharma ADC Technology HDP-102 Non-Hodgkin Lymphoma Phase I Study

Published on 12/05/2025 at 02:35, 6 hours 58 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 3 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 33 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 28 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 33 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 28 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 32 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 33 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 33 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 33 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 48 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 48 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 51 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 18 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 33 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News